NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.82% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.52% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.37% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.07% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.70% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.01% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.16% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.06% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.92% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.71% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.68% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.62% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.53% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.47% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.46% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.40% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.33% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 1.24% |